Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Luminex 100 System Users

October 20, 2006
Inpatient DRGs likely to trump any positive effects on reimbursement from FDA-approval
By a GLG Expert Contributor
Analysis of: FDA Approves Supplemental Use of NovoSeven(R) Coagulation Factor VIIa (Recombinant) for Treatment of Acquired Hemophilia (main.pslgroup.com)
FDA-approval is unlikely to have significant impact upon reimbursement rates for FVIIa, given issues with inpatient DRGs.
October 20, 2006
Expect HPV testing to change screening protocols for cervical cancer
By a GLG Expert Contributor
Analysis of: HPV DNA Testing Likely to Become Primary Cervical Cancer Screening Tool as Vaccine Use Expands, Predict International Experts (www.medicalnewstoday.com)
With HPV vaccination, screening for cervical cancer is likely to shift from PAP cytology as the first step, to HPV testing as the first step that drives subsequent follow-up and testing for the patient.
October 20, 2006
Cure your diabetes with Alzheimer's?
By a GLG Expert Contributor
Analysis of: Pac Man enzyme key to new diabetes, Alzheimer drugs (www.topix.net)
The 3D crystal structure of the primary insulin-degrading enzyme has been determined. Crystal structures can facilitate the development of pharmacologic inhibitors or activators of enzyme acitivity.IDE also mediates the degradation of beta-amyloid proteins. Accumulation of beta-amyloid is key in the...
October 16, 2006
Definite advantages with Illumina, performance will be key
By a GLG Expert Contributor
Analysis of: Duke University's Center for Human Genetics Selects Illumina's Infinium HumanHap550 BeadChip for Landmark Autism Study (biz.yahoo.com)
Affymetrix remains the "gold standard" for chip-based testing, but its costs remain prohibitively high.Illumina provides a solution at significantly lower cost and with additional flexibility. It stands to gain significant market share if it can provide comparable data to that obtained on Affymetri...

Previous Page : 1 211 to 14 of 14

Analytics


Generated at 2009-01-07T19:00:58.307